Global Digital Health and Digital Therapeutics Market Growth (Status and Outlook) 2025-2031
Description
The global Digital Health and Digital Therapeutics market size is predicted to grow from US$ 3980 million in 2025 to US$ 6304 million in 2031; it is expected to grow at a CAGR of 8.0% from 2025 to 2031.
Digital Health and Digital Therapeutics refers to medical technologies that prevent, manage or treat specific diseases through clinically validated software and applications, using digital technology to improve the overall areas of health management, disease prevention, diagnosis, treatment and patient care, covering telemedicine, health monitoring devices, health applications, data analysis, etc.
In recent years, the fields of digital health and digital therapeutics (DTx) are developing rapidly and have become an important part of innovation in the global medical industry. Through technology empowerment, these two fields have improved the efficiency, accessibility and personalization of medical services, and have also promoted profound changes in the way health is managed. From telemedicine to smart health devices to software-based treatment plans, digital health and digital therapy provide patients around the world with more convenient, accurate and personalized medical options.
Digital health is a comprehensive field that covers a wide range of technological applications, such as telemedicine, mobile health applications, health monitoring devices, and health big data analysis. With the increasing severity of global health problems, especially the advent of an aging society, the demand for the digital health market has risen sharply.
The rapid growth of digital health is driven by many factors. First, with the aging of the global population, the incidence of chronic diseases and geriatric diseases has increased, and there is an urgent need for more efficient and convenient health management methods. Second, the advancement of smart devices and mobile Internet technology has made personal health monitoring and management more feasible. For example, smart watches, health monitoring sensors, wearable devices, etc. have become part of daily life, which can collect health data and provide feedback in real time to help users understand their health status. The popularity of telemedicine and video consultations also allows patients to obtain professional medical services anytime and anywhere, reducing the time and geographical restrictions of traditional medical treatment models.
However, despite the rapid development of the digital health market, it also faces some challenges. For example, data privacy and security issues remain core issues in the field of digital health. How to ensure the security of patient data and how to achieve data interoperability and sharing in different medical systems are currently urgent issues to be solved.
LPI (LP Information)' newest research report, the “Digital Health and Digital Therapeutics Industry Forecast” looks at past sales and reviews total world Digital Health and Digital Therapeutics sales in 2024, providing a comprehensive analysis by region and market sector of projected Digital Health and Digital Therapeutics sales for 2025 through 2031. With Digital Health and Digital Therapeutics sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Digital Health and Digital Therapeutics industry.
This Insight Report provides a comprehensive analysis of the global Digital Health and Digital Therapeutics landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Digital Health and Digital Therapeutics portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Digital Health and Digital Therapeutics market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Digital Health and Digital Therapeutics and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Digital Health and Digital Therapeutics.
This report presents a comprehensive overview, market shares, and growth opportunities of Digital Health and Digital Therapeutics market by product type, application, key players and key regions and countries.
Segmentation by Type:
Software
Hardware
Segmentation by Application:
Cardiovascular Disease
Diabetes
Obesity
Other
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Canary Health
Livongo
My mHealth
Omada
Otsuka (Proteus)
Virgin Pulse
DarioHealth Corp
2Morrow
Click Therapeutics
CureApp
AppliedVR
Virta Health
Biofourmis
Akili Interactive
Pear Therapeutics
Provant Health
Lark Health
Propeller Health
Cognoa
Kaia Health
Happify Health
Welldoc
Mango Health
Wellthy Therapeutics
Please note: The report will take approximately 2 business days to prepare and deliver.
Digital Health and Digital Therapeutics refers to medical technologies that prevent, manage or treat specific diseases through clinically validated software and applications, using digital technology to improve the overall areas of health management, disease prevention, diagnosis, treatment and patient care, covering telemedicine, health monitoring devices, health applications, data analysis, etc.
In recent years, the fields of digital health and digital therapeutics (DTx) are developing rapidly and have become an important part of innovation in the global medical industry. Through technology empowerment, these two fields have improved the efficiency, accessibility and personalization of medical services, and have also promoted profound changes in the way health is managed. From telemedicine to smart health devices to software-based treatment plans, digital health and digital therapy provide patients around the world with more convenient, accurate and personalized medical options.
Digital health is a comprehensive field that covers a wide range of technological applications, such as telemedicine, mobile health applications, health monitoring devices, and health big data analysis. With the increasing severity of global health problems, especially the advent of an aging society, the demand for the digital health market has risen sharply.
The rapid growth of digital health is driven by many factors. First, with the aging of the global population, the incidence of chronic diseases and geriatric diseases has increased, and there is an urgent need for more efficient and convenient health management methods. Second, the advancement of smart devices and mobile Internet technology has made personal health monitoring and management more feasible. For example, smart watches, health monitoring sensors, wearable devices, etc. have become part of daily life, which can collect health data and provide feedback in real time to help users understand their health status. The popularity of telemedicine and video consultations also allows patients to obtain professional medical services anytime and anywhere, reducing the time and geographical restrictions of traditional medical treatment models.
However, despite the rapid development of the digital health market, it also faces some challenges. For example, data privacy and security issues remain core issues in the field of digital health. How to ensure the security of patient data and how to achieve data interoperability and sharing in different medical systems are currently urgent issues to be solved.
LPI (LP Information)' newest research report, the “Digital Health and Digital Therapeutics Industry Forecast” looks at past sales and reviews total world Digital Health and Digital Therapeutics sales in 2024, providing a comprehensive analysis by region and market sector of projected Digital Health and Digital Therapeutics sales for 2025 through 2031. With Digital Health and Digital Therapeutics sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Digital Health and Digital Therapeutics industry.
This Insight Report provides a comprehensive analysis of the global Digital Health and Digital Therapeutics landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Digital Health and Digital Therapeutics portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Digital Health and Digital Therapeutics market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Digital Health and Digital Therapeutics and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Digital Health and Digital Therapeutics.
This report presents a comprehensive overview, market shares, and growth opportunities of Digital Health and Digital Therapeutics market by product type, application, key players and key regions and countries.
Segmentation by Type:
Software
Hardware
Segmentation by Application:
Cardiovascular Disease
Diabetes
Obesity
Other
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Canary Health
Livongo
My mHealth
Omada
Otsuka (Proteus)
Virgin Pulse
DarioHealth Corp
2Morrow
Click Therapeutics
CureApp
AppliedVR
Virta Health
Biofourmis
Akili Interactive
Pear Therapeutics
Provant Health
Lark Health
Propeller Health
Cognoa
Kaia Health
Happify Health
Welldoc
Mango Health
Wellthy Therapeutics
Please note: The report will take approximately 2 business days to prepare and deliver.
Table of Contents
155 Pages
- *This is a tentative TOC and the final deliverable is subject to change.*
- 1 Scope of the Report
- 2 Executive Summary
- 3 Digital Health and Digital Therapeutics Market Size by Player
- 4 Digital Health and Digital Therapeutics by Region
- 5 Americas
- 6 APAC
- 7 Europe
- 8 Middle East & Africa
- 9 Market Drivers, Challenges and Trends
- 10 Global Digital Health and Digital Therapeutics Market Forecast
- 11 Key Players Analysis
- 12 Research Findings and Conclusion
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
